Shots: Bio-Thera will take care of full development, and commercial supply of BAT2506 out of the manufacturing facilities in Guangzhou, China. Additionally, the agreement will utilize Pharmapark’s local presence, sales, and marketing capabilities in Russia and other CIS countries Pharmapark to get exclusive rights to distribute and market the product in Russia and other CIS […]Read More
Shots: The submissions are based on P-III GO-VIVA study involves assessing of SIMPONI ARIA in 127 patients aged 2-17yrs. with active pJIA having arthritis in 5or more joints, despite current treatment with methotrexate for at least two mos. The focus of the study is to evaluate PK safety & efficacy of the therapy in pediatric […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
